
|Articles|November 1, 2012
Consider patients' concerns when treating autoimmune blistering disorders
If dermatologists considered the management of autoimmune blistering disorders from the patient's perspective, they might do many things differently. So says John Zone, M.D., co-director of the immunopathology lab at the University of Utah, where he is also chairman of dermatology.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
KT-621 in Atopic Dermatitis: What Early EASI and Pruritus Data Show
2
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
Social Media Mythbusters: Skin Cycling
5














